Non-B DNA-Informed Mutation Burden as a Marker of Treatment Response and Outcome in Cancer
This paper introduces two novel markers, nbTMB and mlTNB, to improve prediction of treatment response and outcomes in cancer by incorporating non-B DNA mutation information.